Tomi Environmental Solutions I Stock Price, News & Analysis
Company Description
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is described as a global decontamination and infection prevention company that focuses on environmental solutions for indoor surface disinfection and broader disinfection and decontamination needs. The company manufactures, sells, and licenses its premier Binary Ionization Technology® (BIT™) platform, which underpins its SteraMist® brand of products. TOMI is classified in the Facilities Support Services industry within the Administrative and Support and Waste Management and Remediation Services sector.
The BIT™ solution, invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, utilizes a low percentage hydrogen peroxide as its only active ingredient. This solution is used to produce a fog of ionized Hydrogen Peroxide (iHP™), represented commercially by the SteraMist® product line. According to the company’s descriptions, iHP™ produces a germ-killing aerosol that behaves like a visual non-caustic gas, enabling high-level disinfection and decontamination of indoor environments and surfaces.
Core technology and SteraMist® platform
TOMI’s business centers on the application of its BIT™ platform through various SteraMist® systems. These systems are designed for environmental surface disinfection and decontamination, including room fogging and treatment of critical spaces. The company notes that its products are intended for a broad spectrum of commercial structures and use sites. These include hospitals and medical facilities, biosafety laboratories, pharmaceutical facilities, cruise ships, commercial and office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI also states that its products and services have been used in single-family homes and multi-unit residential properties.
In addition to portable and service-based applications, TOMI highlights platforms such as the SteraMist Integrated System (SIS), Custom Engineered System (CES), and SteraMist Hybrid System. These offerings are used for automated and integrated decontamination within enclosures, sterilization rooms, and other controlled environments. For example, the company reports multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist iHP into passthrough fill boxes at a global biopharmaceutical company, and installation of a SteraMist Hybrid System in a sterilization room at a private research university facility.
Applications across regulated and high-risk environments
TOMI emphasizes that its technology is used in regulated industries and high-risk environments where contamination control and infection prevention are critical. The company cites applications in life sciences, pharmaceutical manufacturing, cell and gene therapy facilities, 503B compounding, medical device reprocessing, animal research environments, and healthcare-related decontamination. It also describes outreach to the cruise industry, advocating for adoption of hospital-grade disinfection technology such as SteraMist to address pathogens including Norovirus and Legionella on cruise ships.
The company positions its SteraMist iHP technology as part of contamination control strategies in facilities that must meet current Good Manufacturing Practices (cGMP) and other stringent regulatory requirements. TOMI reports that its systems are used for automated room fogging, surface treatment, and whole-facility fogging services, covering areas such as manufacturing suites, quality control laboratories, support spaces, and specialized enclosures. It also notes that its iHP Corporate Service team performs whole-facility fogging services to reset laboratory spaces to operational conditions.
Business activities and service offerings
According to company disclosures, TOMI generates business through manufacturing and sales of SteraMist equipment, recurring sales of its BIT™ solution, licensing of its technology platform, and service offerings. The company references recurring BIT™ solution sales and describes a network of distributors and service providers, including specialized providers for healthcare and mold remediation and decontamination service franchises. TOMI also reports development of standard operating procedure (SOP) packages, installation and operational qualification (IQ/OQ) packages, and performance qualification (PQ) services in connection with SteraMist system deployments.
TOMI states that it develops training programs and application protocols for clients. It also notes that it operates the SteraMist Pro Certified program, which supports the onboarding of service provider companies that use SteraMist iHP technology in their operations. Through these programs and partnerships, TOMI aims to support consistent application of its decontamination technology across various sectors.
Industry affiliations and memberships
The company reports that it is a member in good standing of several professional and industry organizations. These include The American Biological Safety Association, The American Association of Tissue Banks, the Association for Professionals in Infection Control and Epidemiology, the Society for Healthcare Epidemiology of America, the America Seed Trade Association, and The Restoration Industry Association. These affiliations reflect TOMI’s engagement with communities involved in biosafety, infection control, tissue banking, seed trade, and restoration services.
Market focus and project pipeline
TOMI highlights a focus on life sciences and medical device sectors, describing a custom integration pipeline for its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms. The company reports active projects and a pipeline of automated installation projects involving SteraMist Hybrid, CES, and SIS platforms. It notes strategic partnerships with enclosure manufacturers such as ESCO Micro Pte. Ltd., Steelco S.p.A., Pharma Biotech System Components (PBSC), Nuaire, Inc., and Getinge AB, which facilitate integration of its iHP technology into existing enclosure systems used in regulated environments.
The company also references demand from academic institutions, animal research facilities, and decontamination service providers. It describes participation in industry events such as the American Association for Laboratory Animal Science (AALAS) National Meeting, where it showcases its SteraMist SIS platform and engages with research institutions and distributors.
Corporate and listing information
TOMI Environmental Solutions, Inc. is incorporated in Florida and lists its common stock on The Nasdaq Capital Market under the trading symbol TOMZ. In an 8-K filing, the company reports receiving deficiency letters from Nasdaq related to the minimum bid price requirement and minimum stockholders’ equity requirement for continued listing. The company states that these notifications have no immediate effect on the listing or trading of its common stock and that the stock continues to trade on The Nasdaq Capital Market under the symbol TOMZ, while it considers measures to regain compliance with Nasdaq listing rules.
In another 8-K filing, TOMI reports entering into an Equity Purchase Agreement with Hudson Global Ventures, LLC, giving the company the right, but not the obligation, to sell up to a specified amount of its common stock over a defined commitment period, subject to conditions and Nasdaq rules. The company also references plans to file a universal shelf registration statement on Form S-3 to provide flexibility to offer and sell securities up to a stated aggregate amount.
Use environments and sectors served
Across its public descriptions and news releases, TOMI identifies a range of sectors and environments where its technology is applied:
- Hospitals and medical facilities
- Biosafety laboratories and pharmaceutical facilities
- Cell and gene therapy manufacturing sites and other life sciences operations
- Cruise ships and maritime environments
- Commercial and office buildings, hotels and motels
- Schools and restaurants
- Meat and produce processing facilities
- Military barracks, police and fire departments
- Athletic facilities
- Single-family homes and multi-unit residences
These stated use cases position TOMI within markets where infection prevention, contamination control, and environmental decontamination are central operational concerns.